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Summary 
Insulin receptor substrate 1 (IRS-1) is the principle cellular substrate for insulin and insulin-like 
growth factor I (IGF-I) receptor signaling. After phosphorylation of tyrosine residues within 
the YMXM or YXXM motifs, IRS-1 associates with phosphatidylinositol-3 kinase (PI3K). This 
signaling pathway and the presence of an IRS-l-like molecule have been demonstrated in IRS-1- 
transfected and in nontransfected hematopoietic cell lines, respectively. IGF-I has been implicated 
in lymphocyte development and function, and recently,  we showed that functional type-I IGF 
receptors are present on human thymocytes and peripheral T  cells. In this study, we addressed 
IGF-I signal transduction in nontransformed, freshly isolated,  human thymocytes, as well as in 
blood T  cells. Using Western blot analysis, we found that IGF-I induced phosphorylation of 
a 160-180-kD protein (pp170) in human thymocytes and that phosphorylated pp170 becomes 
associated with PI3K and is recognized by anti-IRS-1. In blood T  cells, this immunoreactive 
IRS-1 (irlRS-1) is less abundantly expressed than in thymocytes, as assessed with immunoblotting. 
As a consequence, phosphorylated pp170 was not or hardly detectable  after  stimulation with 
IGF-I, and irlRS-1 was not detected in PI3K immunoprecipitates  from lysates of IGF-I-stimulated 
T cells. However, IGF-I induced the tyrosine phosphorylation of other cellular proteins, indicating 
that differential  expression of irlRS-1 contributes to a distinct signaling pathway in T  cells. 
I 
nsulin receptor substrate 1 (IRS-1) is a common element 
in insulin and  type I  insulin-like growth factor (IGF) 
receptor signaling. This cytosolic protein contains multiple 
potential serine, threonine, and tyrosine phosphorylation sites 
(1, 2) and undergoes tyrosine phosphorylation immediately 
after  stimulation with  insulin or  IGF-I  (1,  3-5).  Several 
tyrosine-phosphorylated sites are included in the consensus 
sequences YMXM and YXXM, which represent recogni- 
tion motifs for SH2 domain-containing target proteins. IRS-1 
associates with phosphatidylinositol-3 kinase (PI3K) via the 
SH2 domains of the 85-kD regulatory subunit (1), resulting 
in the activation of the enzyme (6).  In addition, IRS-1 is 
a docking protein for other regulatory enzymes such as growth 
factor receptor-bound protein 2 and SH2 containing tyro- 
sine phosphatase 2 (7). 
Recently, IRS-1 has been implicated in IL-4 and insulin 
signaling in hematopoietic cells that were transfected  with 
IRS-1 (8, 9). Furthermore, IL-4, insulin, and IGF-I induced 
phosphorylation of an IRS-l-like molecule, 4PS, in IL-3- 
dependent murine hematopoietic cell lines and its associa- 
tion with PI3K (8). In addition, II.-7 activates PI3K in human 
thymocytes (10). The use of IRS-l-like molecules and PI3K 
as common elements in IGF-I and cytokine signaling might 
explain the cytokine-like activity of IGF-I on lymphocyte de- 
velopment and function (11-14). The signal  transduction 
pathways for IGF-I have been studied mainly in cell lines or 
transfected  cell lines expressing high levels of receptors or 
IRS-1. In this study, we addressed the role of IRS-1 in IGF-I 
signaling in freshly isolated human thymocytes and mature 
peripheral T  cells. 
We have demonstrated previously that functional type-I 
IGF receptors are expressed on all developmental stages of 
human thymocytes and on the majority of peripheral T cells 
(14, 15). The in vitro proliferation of both thymocytes (15a) 
and peripheral T cells (16-19) is stimulated by IGF-I. Others 
showed that the presence of type I IGF receptors in T cells 
is essential for progression to the S phase of the cell cycle 
(20). In this study, we demonstrate that immunoreactive IRS-1 
(irIRS-1) is the main tyrosine kinase substrate in IGF-I sig- 
naling in thymocytes, which, after stimulation, associates  with 
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dantly expressed and, in contrast to several other cellular pro- 
teins, not or hardly phosphorylated after IGF-I stimulation. 
Materials and Methods 
Reagents.  Recombinant human IGF-I was a gift from Dr. Jea- 
tran (Lilly Research Laboratories, Indianapolis, IN). A polyclonal 
Ab to IRS-1 was kindly provided  to us by Dr. J. A. Maassen (Depart- 
ment of Medical Biochemistry, University of Leiden, The Nether- 
lands). This Ab is directed against a peptide corresponding to the 
amino acid sequence 581-860 of rat  IRS-1. Rabbit  anti-PI3K, 
directed against the p85 subunit, was obtained from Upstate Bio- 
technology, Inc. (Lake  Placid, NY), and antiphosphotyrosine (anti- 
PY, clone PY20) was from Transduction Laboratories (Lexington, 
KY). Peroxidase-conjugated  donkey anti-rabbit  IgG, peroxidase- 
conjugated sheep anti-mouse IgG, and nitrocellulose membranes 
(Hybond C, 0.45 #m) were obtained from Amersham  International 
(Amersham, UK). Protein A was purchased from Pharmacia  (Upp- 
sala, Sweden). 
Cells.  Thymic tissue was obtained from patients undergoing 
cardiac surgery. The patients ranged in age from 5 d to 5.5 yr. 
The tissue was cut into small pieces in MEM, and single cell sus- 
pensions were obtained by pressing these pieces against a stainless 
steel mesh. Dead cells and erythrocytes were removed by centrifu- 
gation on Ficoll-Paque (Pharmacia) density gradients (1.077 g/ml) 
at 1,000 g for 20 rain at room temperature. PBMCs were purified 
from heparinized blood from healthy adult donors by centrifuga- 
tion on Ficoll-Paque, as described for thymocytes. T cells were iso- 
lated from PBMC by rosetting with sheep erythrocytes that were 
pretreated  with  2-aminoethyl-isothiouronium bromide  (Sigma 
Chemical Co., St. Louis, MO)  (21). 
Cell Stimulation.  Purified  thymocytes and T cells (108 cells/ml) 
were taken into MEM containing 0.2% BSA and preincubated at 
37~  for 1 h. After incubation with 10 -s M IGF-I, 1 ml ice-cold 
PBS was added to 0.4 ml cell suspension, and the cells were cen- 
trifuged for 30 s at 10,000 g at 5~ 
Immunoprecipitation.  40  x  106 cells were lysed in 100 #1 ice- 
cold lysis  buffer (1% digitonin, 10 mM Tris, pH 7.5, 150 mM NaCI, 
10 mM Na4P2OT, 10 mM NaF, 0.4 mM EDTA, 0.4 mM Na3VO2, 
0.1 mM phenyl-methylsulfonyl  fluoride, 1 #g/ml aprotinin, 1 #g/ml 
leupeptide, and 1 #g/ml cO-antitrypsin) at 5~  for 15 rain. In- 
soluble material was pelleted at 10,000 g for 15 min at 5~  and 
supernatants were incubated with anti-PI3K (1:20) for 2 h at 5~ 
Immunocomplexes were precipitated with protein A beads (1% 
vol/vol). Immunoprecipitates were subsequently washed six times 
with buffer (containing 0.2% digitonin and otherwise of the same 
composition as lysis  buffer) and denatured in Laemmli  sample buffer 
containing 2-ME (22). 
Immunoblotting.  For detection of tyrosine phosphorylated pro- 
teins, IRS-1 and PI3K in thymocytes and T cells, whole cells were 
solubilized in Laemmli sample buffer containing 2-ME. Proteins 
were resolved by SDS-PAGE using a 4% stacking gel and a 7% 
or 10% separating gel (100  x  70  x  1 mm) at 100 V, and trans- 
ferred to nitrocellulose membranes in Towbin buffer containing 
20% methanol (23) using a semi-dry transfer cell (Bio-Rad Labora- 
tories, Richmond,  CA) at 0.8 mA/cm  2 for 2 h at room temper- 
ature. The membranes were blocked overnight at 5~  in TBS (25 
mM Tris, pH 7.5, 125 mM NaC1) containing 3% BSA (Promega 
Corp.,  Madison, WI). Blots were incubated with anti-PY (0.4 
#g/ml) in TBS containing 0.02% Tween 20 and 1% BSA for 2 h 
at 5~  Subsequently, the blots were washed twice for 10 min in 
TBS containing 0.02% Tween 20 and incubated with peroxidase- 
conjugated anti-mouse IgG (1:20,000). After two washing steps, 
the blots were exposed to detection solution for enhanced chem- 
ical luminescence  and autoradiographed according to the manufac- 
turers procedure (Amersham International). Subsequently, anti- 
bodies were removed  by stripping in 62 mM Tris, pH 6.7, containing 
2% SDS and 100 mM/~-mercaptoethanol  for 30 min at 50~  After 
re-blocking in TBS/3%  BSA (Sigma Chemical Co.), blots were 
incubated with anti-IRS-1 (1:1000) in TBS/1% BSA and stained 
with peroxidase-conjugated  anti-rabbit IgG (1:20,000). After de- 
tection, blots were stripped, reblocked, and immunoblotted with 
anti-PI3K (1:2,000) according  to the same  procedure. The specificity 
of anti-PY was confirmed by inhibiting  binding  with phenyl- 
phosphate. 
Results and Discussion 
Tyrosine Phosphorflation of irlRS-1 and Association with PI3K 
in Thymocytes.  We first investigated the effect of IGF-I on 
the  tyrosine phosphorylation state of cellular  proteins  in 
thymocytes. It appeared  that a high molecular weight pro- 
tein, which was not detectable with anti-PY before incuba- 
tion with IGF-I, was markedly phosphorylated within 3 rain 
of incubation. The degree of phosphorylation of this protein 
was further increased after 10 and 20 min (Fig.  1 A). This 
result was confirmed with cells from three donors. In thymo- 
cytes obtained from two other donors, the phosphorylation 
at 10 min was decreased compared with that after 3 min of 
incubation (data not shown). 
A high molecular weight band, designated pp170,  which 
was detected by anti-IRS-1, comigrated with a phosphorylated 
band at 160-180  kD (Fig.  1 A). This is in accordance with 
other observations showing that IRS-1 migrates as a 165-185- 
kD protein on a PAGE gel (3, 4, 24). To test whether pp170 
associated with PI3K after stimulation with IGF-I, cell lyo 
sates were immunoprecipitated with anti-PI3K antibodies and 
immunoblotted with anti-PY, anti-IRS-1, and anti-PI3K. 
Fig. 1 B shows that approximately equal amounts of the p85 
subunit of PI3K were precipitated. Furthermore, pp170 was 
detected with both anti-PY and anti-IRS-1 after a 5-min stim- 
ulation with IGF-I. In contrast, pp170 was not detected in 
anti-PI3K immunoprecipitates with anti-PY or anti-IRS-1 
before stimulation with IGF-I (Fig. 1 B). As depicted in Fig. 
1 C, coprecipitation of ppl70 with PI3K was also markedly 
increased after stimulation with IGF-I in thymocytes from 
two other donors. 
These results indicate that IGF-I induces the association 
of PI3K with irlRS-1 in human thymocytes. Furthermore, 
irlRS-1 is the major tyrosine-phosphorylated substrate in re- 
sponse  to IGF-I. The presence  of an IRS-l-like molecule, 
4PS, has been demonstrated in the IL-3-dependent murine 
hematopoietic cell lines FDC-P1 and FDC-P2.4PS was phos- 
phorylated after stimulation with IGF-I, insulin, or IL-4, and 
it appeared  to be similar but not identical to IRS-1 as as- 
sessed by V8 protease digestion (8).  Further investigations 
are necessary to identify irlRS-1 in human thymocytes and 
to address  the role of this molecule in cytokine signaling. 
Tyrosine Pho~horylation in Pen'pheral T Cells.  Because  several 
functions of mature T  cells can be influenced by IGF-I (16, 
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association  of irIRS-1 with PI3K  in thymocytes.  (,4) Tyro- 
sine phosphorylation.  40 x 106 cells  were incubated  in the 
absence of IGF-I or in the presence of 10- s M IGF-I. Cell 
lysates  were  resolved  by SDS-PAGE, transferred  to nitrocel- 
lulose, and immunoblotted  with anti-PY (c~PY) or anti- 
IRS-1 (~IRS-1). (/3) Association  of irIRS-1 with PI3K in 
thymocytes  from  donor 1. Cells  were  incubated  for 10 min 
with or without 10 -s M IGF-I. Cell lysates  were immu- 
noprecipitated with antibodies to PI3K (~PI3K). Precipi- 
tated proteins were revealed  by Western  blotting and anti- 
bodies to PY, IRS-1, and PI3K. (C) Association  of irlRS-1 
with PI3K in thymocytes  from donors 2 and 3. Thymo- 
cytes were incubated  with different  concentrations  of IGF-I, and cell lysates  were immunoprecipitated  with c~PI3K as described for Fig. 1 B. The 
irlKS-1 in anti-PI3K  immunoprecipitates  was stained  with c~PY or cdRS-1. Molecular  masses of prestained marker proteins (Bio Rad Laboratories) 
are indicated in kilodaltons. 
17), we also addressed the role of IRS-1 in purified periph- 
eral blood T cells. We demonstrated that the majority of  blood 
T cells possess approximately the same number of type I IGF 
receptors  with  the  same  Kd  as  human  thymocytes  (14; 
Kooijman, R., et al., manuscript submitted for publication). 
As depicted in Fig. 2 A, IGF-I increased  the phosphoryla- 
tion of several proteins. However, tyrosine phosphorylation 
of pp170 could not be detected in peripheral T cells after stim- 
ulation with IGF-I (Fig. 2 A). Even when higher concentra- 
tions of IGF-I (10- 7 M) and longer incubation times (up to 
30 rain) were used, phosphorylated pp170 was not detected 
(data not shown). Furthermore, irlRS-1 was not found in 
immunoprecipitates with anti-PI3K after stimulation with 
IGF-I (Fig.  2 B). To address  the ability of IGF-I to induce 
tyrosine phosphorylation of pp170 in blood T  cells, immu- 
noblots were also incubated with an alternative anti-PY Ab, 
AB-2. Using this Ab,  we detected a relatively weak phos- 
phorylation of pp170 in IGF-I-stimulated T cells from two 
out of four donors (Fig. 2 C). It should be noted that IGF-I 
Figure  2.  IGF-I-induced  tyrosine  phosphorylation  in human periph- 
eral blood  T cells and precipitation  of proteins with anti-PI3K. (A) Phos- 
phorylation status of cellular proteins before and after stimulation  of T 
cells with IGF-I.  Phosphorylated  cellular  proteins from stimulated  thymo- 
cytes were run on the same gel (Thy). (B) Precipitation  with anti-PI3K. 
Experiments were performed  as described  in Fig. 1. The data in Fig. 2, 
A and B, are representative  of four independent  experiments. (C) Phos- 
phorylation status of cellular proteins before and after stimulation  with 
IGF-I  as measured  with the AB-2  anti-PY  Ab (0.4/xg/ml;  Oncogene  Science, 
Manhasset, NY). With this Ab, phosphorylation  of pp170 was detected 
in two out of four independent experiments. 
incubation of peripheral T  cells does increase  the tyrosine 
phosphorylation state of a number of cellular proteins. This 
effect is already evident after 1 rain of incubation and includes 
phosphoproteins of 55,  85,  and 130 kD (Fig. 2, A  and C). 
Overall, these data indicate that in peripheral blood T cells, 
IRS-1 is not a principle substrate in IGF-I signaling but that 
other as yet not defined signaling routes mediate the effects 
of IGF-I in T cell function. The identity of the tyrosine ki- 
nase substrates  in T cells remains to be established.  Potential 
candidate molecules are the substrates that are tyrosine phos- 
phorylated by the insulin receptor such as the p85  subunit 
of PI3K (25).  However, the phosphorylated 85-kD protein 
in peripheral T cells is not the p85 subunit of PI3K because 
it was not detected in anti-PI3K immunoprecipitates with 
anti-PY  antibodies  (data  not  shown).  The  55-kD  phos- 
phoprotein in T cells might be one of the 52-62 kD proteins 
that are tyrosine phosphorylated in insulin-treated cells. In 
Chinese hamster ovary cells, the 52-kD SH2-containing pro- 
tein (SHC) was phosphorylated in response to insulin (26). 
Furthermore, insulin-induced phosphorylation of 60-62-kD 
proteins was found in Chinese hamster ovary cells and in rat 
adipocytes. These proteins were associated either with GTPase- 
activating protein (26-28) or with PI3K (27,  29).  Notably, 
the 55-kD protein that was phosphorylated in response  to 
IGF-I in T  cells was not detected in PI3K immunoprecipi- 
tares (data not shown).  Finally,  the 130-kD  substrate may 
be an ecto-ATPase (pp120/HA4) that can be phosphorylated 
by the insulin receptor in hepatoma cells (30,  31). Interest- 
ingly, extracellular ATPase activity has been found on human 
peripheral  T  cells (32). Furthermore, tyrosine phosphoryla- 
tion of substrates  with a comparable molecular weight oc- 
curred  after stimulation of T  cells  via the CD2  or CD3 
pathway (33,  34). 
Expression of irlRS-1 and  PI3K  in  Thymocytes and  T 
Cells.  The low or absent induction of tyrosine-phosphoryl- 
ated pp170  in peripheral T  cells could either be the result 
of a low cellular expression of IRS-1 or, alternatively, of the 
inability of IGF-I to induce IRS-1 phosphorylation. We there- 
fore compared the expression of this molecule in T cells with 
its expression in thymocytes. It appeared that there was much 
less irlRS-1 in T cells compared with thymocytes. Whereas 
irlKS-1 was always detected in whole cell lysates of thymo- 
cytes, in T  cells, irlRS-1 was hardly or not detectable (Fig. 
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out of four donors suggests that the phosphorylated ppl70 
in Fig. 2 C  is IRS-1 or an IRS-l-like tyrosine kinase sub- 
strate.  In contrast to the expression of IRS-1,  the level of 
PI3K in T  cells was higher than in thymocytes (Fig.  3 C). 
Taken together, our data demonstrate that IGF-I signaling 
in thymocytes differs from the signaling pathway in periph- 
eral T  cells.  In thymocytes, ppl70 is the principle tyrosine 
kinase substrate, whereas in T cells, pp170 is either not phos- 
phorylated or only a minor substrate.  This difference appears 
to be a consequence of differential expression  of irlRS-1 in 
thymocytes and T cells. Although we did not find any differ- 
ences in irlRS-1  expression or in IGF-I signaling between 
thymocytes from 5-d-old and 5-yr-old children, we cannot 
formally exclude the possibility that the differences  in sig- 
naling between thymocytes and T cells are age related rather 
than dependent on the developmental T  cell  stage. 
The differential effects of IGF-I on tyrosine phosphoryla- 
tion in thymocytes and T cells are remarkable because IGF-I 
can stimulate the proliferation of  both thymocytes and T cells 
(15a,  19). Possibly,  a low level of irlKS-1 phosphorylation 
is  sufficient  for  the  effects  in  T  cells.  Alternatively,  the 
stimulating effect of IGF-I might be effected at different control 
points of the cell cycle. For instance, we found that IGF-I 
potentiates the transition of T  cells from the Go to the G1 
phase of the cell cycle, and not the proliferation of IL-2-de- 
was enhanced  using  a computer  program 
Canada). (C) PI3K  was always  present 
donors tested. 
F~re 3.  Expression  ofirlRS-1 
and PI3K in thymocytes  and pe- 
ripheral blood T cells. 106 cells 
were resolved  in sample  buffer  and 
subjected to SDS-PAGE. IKS-1 
and PI3K  were  detected  by immu- 
noblotting and incubation  with 
antibodies to IRS-1 and FI3K. 
The expression  of  immunoreactive 
IRS-1 was variable and detected 
in T cells  from  two of  five  donors. 
(A)  Donor without detectable 
IRS-1. (/3)  Donor  with low levels 
of IRS-1. In Fig. 3 B, the contrast 
(Photopaint; Corel  Corp., Ottawa, 
in peripheral T cells from all five 
pendently growing T cells (Kooijman, R., et al., manuscript 
in preparation for publication). On the other hand, in thy- 
mocytes, IGF-I does  stimulate the proliferation of cycling 
cells (15a). 
Type-I IGF receptors are differentially expressed on different 
activation stages  of peripheral T  cells (15), indicating that 
responsiveness  for IGF-I in different maturation and activa- 
tion stages can be regulated by differential receptor expres- 
sion. The data presented here are suggestive of differential 
postreceptor signaling pathways in different T  cell stages. 
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